Stocktoria
CytoDyn Inc. CYDY
OTC · OOTC · stock · Pharmaceutical Preparations · website · IPO 2005-11-17
CytoDyn Inc. (CYDY) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend.
4/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Price from month-end closes (Yahoo) — for reference, not real-time.
Market cap$340M
P / E90.7×
Revenue trend · last 3y · up
How it ranks in Manufacturing · percentile among 1829 companies
Piotroski Fstronger than 44%
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Detailed pages
Sector peers · similar-size Manufacturing companies
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CYDY | CytoDyn Inc. | 4/9 | — | 90.7 | — |
| JNJ | JOHNSON & JOHNSON | 4/9 | — | 22.9 | +6% |
| LLY | ELI LILLY & Co | 7/9 | — | 55.1 | +44.7% |
| MRK | Merck & Co., Inc. | 4/9 | — | 17.4 | +1.3% |
| PFE | PFIZER INC | 4/9 | — | 17.8 | -1.6% |
| ABBV | AbbVie Inc. | 7/9 | -0.34 | 105.9 | +8.6% |
| BMY | BRISTOL MYERS SQUIBB CO | 7/9 | — | 16.7 | -0.2% |
FAQ
Is CYDY financially healthy?
CytoDyn Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does CYDY pay a dividend?
No, CytoDyn Inc. does not currently pay a dividend.
Source: SEC EDGAR filings · CIK 0001175680 · as of 2025-05-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.